Table 2.
Indications | Before medication review | After medication review | ||
---|---|---|---|---|
n (%) | Approved indicationa | n (%) | Approved indicationa | |
Psychosis or psychotics symptoms | 80 (37) | 77b | 63 (38) | 61b |
BPSD | 11 (5) | 11 | 8 (5) | 8 |
Nausea | 4 (2) | – | 2 (1) | – |
Anxiety | 61 (28) | – | 50 (30) | – |
Depression | 1 (0.5) | – | 1 (0.6) | – |
Dementia | 19 (9) | – | 11 (7) | – |
Bipolar disease | 6 (3) | 5c | 6 (4) | 5c |
Sleep | 1 (0.5) | – | – | – |
None specified | 32 (15) | – | 23 (14) | – |
BPSD behavioural and psychological symptoms in dementia
aAccording to Swedish National Board of Health and Welfare (2010) (indicators for the evaluation of quality in drug use of the elderly)
bThree patients before and 2 patients after medication review with Lewy body dementia treated with antipsychotics for psychotic symptoms
cOlanzapine approved